Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Nanogen to Host Fourth Quarter Conference Call and Webcast on February 20, 2007

Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, will host a conference call on Tuesday, February 20, 2007 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2006 fourth quarter financial results. The financial results press release will be issued at close of market on February 20. Interested investors and others may participate in the conference call by dialing 877-407-9205 for US/Canada participants and 201-689-8054 for international participants.

Nanogen to Host Fourth Quarter Conference Call and Webcast on February 20, 2007

SAN DIEGO, CA | Posted on February 19th, 2007

Audio of management's presentation will be available via live webcast on the investor relations section of Nanogen's corporate website at , and will be archived for 90 days. A digital recording of the call will also be available for 48 hours, beginning two hours after the completion of the conference call on February 20, and can be accessed via telephone at 877-660-6853 for US/Canada participants and (201) 612-7415 for international participants. The account number, 286, along with the conference ID, 231215, will be required to listen to the playback.


About Nanogen
Nanogenís advanced technologies provide researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately help treat disease. The company's products include real-time PCR reagents, the NanoChipģ electronic microarray platform and a line of rapid, point-of-care diagnostic tests. Nanogenís ten years of pioneering research involving nanotechnology holds the promise of miniaturization and continues to be supported for its potential for diagnostic and biodefense applications. For additional information please visit Nanogenís website at .

Nanogen Forward-Looking Statement

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including whether patents owned or licensed by Nanogen will be developed into products, whether the patents owned by Nanogen offer any protection against competitors with competing technologies, whether products under development can be successfully developed and commercialized, whether results reported by our customers or partners can be identically replicated, and other risks and uncertainties discussed under the caption "Factors That May Affect Results" and elsewhere in Nanogenís Form 10-K or Form 10-Q most recently filed with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Nanogen disclaims any intent or obligation to update these forward-looking statements.

For more information, please click here

Nanogen, Inc.
Robert Saltmarsh, Chief Financial Officer, 858-410-4600
Suzanne Clancy, Corporate Communications, 858-410-4688

Porter Novelli Life Sciences
Kim Richards, Media & Investor Relations, 619-849-5377

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


UTA researcher to build internal nanotechnology device to simplify blood sugar testing: Medical technologies December 1st, 2015

Tiny octopods catalyze bright ideas: Rice-led study shows plasmonic sensors and catalysts need not be mutually exclusive November 30th, 2015

Nanoparticles simplify DNA identification and quantification November 27th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015


UTA researcher to build internal nanotechnology device to simplify blood sugar testing: Medical technologies December 1st, 2015

Graphene-Coated Wearable 'E-Textile' Can Alert Wearer To Presence Of Dangerous Gases December 1st, 2015

IU chemists craft molecule that self-assembles into flower-shaped crystalline patterns:'Tricarb' research laid foundation for university's new $1.2 million materials science grant from National Science Foundation December 1st, 2015

New study reveals what's behind a tarantula's blue hue: Researchers uncover nanostructures in exoskeleton of blue-haired tarantulas November 30th, 2015

Financial Reports

Haydale Announce Year End Results November 3rd, 2015

Harris & Harris Group to Host Conference Call on Third-Quarter 2015 Financial Results on November 12, 2015 October 23rd, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Nanostart AG: First-half figures 2015 published and new supervisory board elected : Publication of first-half figures 2015 - Shareholders' meeting elected new supervisory board August 22nd, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic